NO952194L - Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer - Google Patents

Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer

Info

Publication number
NO952194L
NO952194L NO952194A NO952194A NO952194L NO 952194 L NO952194 L NO 952194L NO 952194 A NO952194 A NO 952194A NO 952194 A NO952194 A NO 952194A NO 952194 L NO952194 L NO 952194L
Authority
NO
Norway
Prior art keywords
alkyl
treatment
spirofuranone
derivatives
optionally substituted
Prior art date
Application number
NO952194A
Other languages
English (en)
Other versions
NO952194D0 (no
Inventor
Alexander Kover
Iii James Loch
George Mullen
Edwin Shen-Chou Wu
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225497A external-priority patent/GB9225497D0/en
Priority claimed from GB929225498A external-priority patent/GB9225498D0/en
Priority claimed from GB939316531A external-priority patent/GB9316531D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of NO952194D0 publication Critical patent/NO952194D0/no
Publication of NO952194L publication Critical patent/NO952194L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelser av formel (I), hvori ring A er en ring av formel (AI) eller (All) (hvori splroatonet er angitt ved "). R1 betyr H eller alkyl-C^; R^ betyr -(CH2)n-OR^. -(CH^-CfOjR4. fluoralkyl-C^. cyanoalkyl-C eller alkyl-C., substituert med en 4-7-leddet eventuelt umettet heterocykllsk ring; R3 betyr H, alkyl-C , (eventuelt substituert med alkoksy-C., ), cykloalkyl-C,_7. en 4-7-leddet eventuelt unettet heterocykllsk ring, fenyl (eventuelt substituert med halogen, hydroksy eller alkyl-C., ), eller benzyl (eventuelt substituert med halogen, hydroksy eller alkyl-C.,); R4 betyr OR5, NR^7. N(OR6)R7 eller alkyl-C. ,; R5 betyr H, alkenyl-C , alkynyl- 2-6' Cg, eller alkyl-C., (eventuelt substituert med fenyl); R6 og R7 betyr uavhengig av hverandre H eller alkyl- C._,; R° betyr H eller alkyl-C. ,; n er 2-5; m er 1-5; p er l eller 2; og farmasøytisk akseptable salter derav; er nyttige ved behandlingen av neurodegeneratlve sykdomstilstander.
NO952194A 1992-12-05 1995-06-02 Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer NO952194L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929225497A GB9225497D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB929225498A GB9225498D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB939316531A GB9316531D0 (en) 1993-08-10 1993-08-10 Pharmacologically active compounds
PCT/GB1993/002500 WO1994013678A1 (en) 1992-12-05 1993-12-06 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders

Publications (2)

Publication Number Publication Date
NO952194D0 NO952194D0 (no) 1995-06-02
NO952194L true NO952194L (no) 1995-06-02

Family

ID=27266497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952194A NO952194L (no) 1992-12-05 1995-06-02 Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer

Country Status (10)

Country Link
EP (1) EP0672046A1 (no)
JP (1) JPH08503955A (no)
KR (1) KR950704322A (no)
AU (1) AU5655394A (no)
CA (1) CA2150947A1 (no)
FI (1) FI952733A7 (no)
IL (1) IL107881A0 (no)
MX (1) MX9307679A (no)
NO (1) NO952194L (no)
WO (1) WO1994013678A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270884A1 (en) * 1997-01-27 1998-07-30 Haile Tecle Single pot process for producing (z)-azabicyclo oxime ethers
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
BRPI0418374A (pt) * 2004-01-08 2007-05-22 Hoffmann La Roche derivados de diaza-espiropiperidina como inibidores de transportador 1 de glicina e transportador 2 de glicina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives
JPH03153690A (ja) * 1989-11-10 1991-07-01 Yamanouchi Pharmaceut Co Ltd ヘテロ環スピロ誘導体及びその製造法
IE914238A1 (en) * 1990-12-19 1992-07-01 Fisons Corp Novel spirofurane derivatives

Also Published As

Publication number Publication date
KR950704322A (ko) 1995-11-17
AU5655394A (en) 1994-07-04
MX9307679A (es) 1994-06-30
NO952194D0 (no) 1995-06-02
EP0672046A1 (en) 1995-09-20
FI952733A0 (fi) 1995-06-05
JPH08503955A (ja) 1996-04-30
CA2150947A1 (en) 1994-06-23
IL107881A0 (en) 1994-04-12
FI952733A7 (fi) 1995-06-05
WO1994013678A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
NO976085L (no) Difenylmetylen-piperidin-derivater
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
ATE205206T1 (de) Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
ES2164716T3 (es) Compuestos triciclicos de carbamato utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas.
NO911041L (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
ES2100222T3 (es) Derivados del acido aminoalcansulfonico y compuestos farmaceuticos a utilizar para prevenir o tratar afecciones cardiacas.
DE69209128D1 (de) Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
FR2617476B1 (fr) Nouveaux derives polycycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
NO934227L (no) Pyrrolderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
ES2087173T3 (es) Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
FI810103L (fi) Nya 2,3-dihydro-imidazo /1,2-b/ pyridazinderivat foerfarande foer deras framstaellning och deras terapeutiska anvaendning
EP0317292A3 (en) New antibiotics of the mureidomycin group, their preparation, and their therapeutic use
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
RU94033470A (ru) Циклогексановые производные, фармкомпозиция на их основе и способ лечения
ES8101045A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
FI912733A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten /(1-aryylipyrrolidin-2-yyli)metyyli/piperatsiinijohdannaisten valmistamiseksi
KR950704322A (ko) 스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders)
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen